Establishment of Renal Cell Lines Derived from S2 Segments of the Proximal Tubule

1991 ◽  
Vol 14 (3) ◽  
pp. 128-139 ◽  
Author(s):  
Christine Fauth ◽  
Danielle Chabardès ◽  
Maria Allaz ◽  
Madeleine Garcia ◽  
Bernard Rossier ◽  
...  
2004 ◽  
Vol 287 (2) ◽  
pp. C365-C372 ◽  
Author(s):  
Ralf R. Regeer ◽  
Daniel Markovich

The sat-1 transporter mediates sulfate/bicarbonate/oxalate anion exchange in vivo at the basolateral membrane of the kidney proximal tubule. In the present study, we show two renal cell lines [Madin-Darby canine kidney (MDCK) and porcine proximal tubular kidney (LLC-PK1) cells] that similarly target sat-1 exclusively to the basolateral membrane. To identify possible sorting determinants, we generated truncations of the sat-1 cytoplasmic COOH terminus, fused to enhanced green fluorescence protein (EGFP) or the human IL-2 receptor α-chain (Tac) protein, and both fusion constructs were transiently transfected into MDCK cells. Confocal microscopy revealed that removal of the last three residues on the sat-1 COOH terminus, a putative PDZ domain, had no effect on basolateral sorting in MDCK cells or on sulfate transport in Xenopus oocytes. Removal of the last 30 residues led to an intracellular expression for the GFP fusion protein and an apical expression for the Tac fusion protein, suggesting that a possible sorting motif lies between the last 3 and 30 residues of the sat-1 COOH terminus. Elimination of a dileucine motif at position 677/678 resulted in the loss of basolateral sorting, suggesting that this motif is required for sat-1 targeting to the basolateral membrane. This posttranslational mechanism may be important for the regulation of sulfate reabsorption and oxalate secretion by sat-1 in the kidney proximal tubule.


2020 ◽  
Vol 21 (9) ◽  
pp. 3078
Author(s):  
Mojgan Naghizadeh Dehno ◽  
Yutao Li ◽  
Hans Weiher ◽  
Ingo G.H. Schmidt-Wolf

Cytokine-induced killer (CIK) cells are heterogeneous, major histocompatibility complex (MHC)-unrestricted T lymphocytes that have acquired the expression of several natural killer (NK) cell surface markers following the addition of interferon gamma (IFN-γ), OKT3 and interleukin-2 (IL-2). Treatment with CIK cells demonstrates a practical approach in cancer immunotherapy with limited, if any, graft versus host disease (GvHD) toxicity. CIK cells have been proposed and tested in many clinical trials in cancer patients by autologous, allogeneic or haploidentical administration. The possibility of combining them with specific monoclonal antibodies nivolumab and ipilimumab will further expand the possibility of their clinical utilization. Initially, phenotypic analysis was performed to explore CD3, CD4, CD56, PD-1 and CTLA-4 expression on CIK cells and PD-L1/PD-L2 expression on tumor cells. We further treated CIK cells with nivolumab and ipilimumab and measured the cytotoxicity of CIK cells cocultured to renal carcinoma cell lines, A-498 and Caki-2. We observed a significant decrease in viability of renal cell lines after treating with CIK cells (p < 0.0001) in comparison to untreated renal cell lines and anti-PD-1 or anti-CTLA-4 treatment had no remarkable effect on the viability of tumor cells. Using CCK-8, Precision Count Beads™ and Cell Trace™ violet proliferation assays, we proved significant increased proliferation of CIK cells in the presence of a combination of anti-PD-1 and anti-CTLA-4 antibodies compared to untreated CIK cells. The IFN-γ secretion increased significantly in the presence of A-498 and combinatorial blockade of PD-1 and CTLA-4 compared to nivolumab or ipilimumab monotreatment (p < 0.001). In conclusion, a combination of immune checkpoint inhibition with CIK cells augments cytotoxicity of CIK cells against renal cancer cells.


2007 ◽  
Vol 83 (12) ◽  
pp. 1635-1638 ◽  
Author(s):  
Matthew Laugharne ◽  
Sarah Cross ◽  
Sarah Richards ◽  
Charlotte Dawson ◽  
Laura Ilchyshyn ◽  
...  

2002 ◽  
Vol 183 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Gregory J. Finn ◽  
Emma Kenealy ◽  
Bernadette S. Creaven ◽  
Denise A. Egan

PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e85594 ◽  
Author(s):  
Daisuke Ogawa ◽  
Jun Eguchi ◽  
Jun Wada ◽  
Naoto Terami ◽  
Takashi Hatanaka ◽  
...  

2013 ◽  
Vol 02 (03) ◽  
pp. 25-30 ◽  
Author(s):  
Alexandra H. Heussner ◽  
Daniel R. Dietrich

1988 ◽  
Vol 255 (2) ◽  
pp. C181-C191 ◽  
Author(s):  
T. Nakanishi ◽  
R. S. Balaban ◽  
M. B. Burg

In renal medullas during antidiuresis, the extracellular fluid is hyperosmotic because of high concentrations of NaCl and urea. Under those conditions, the cells contain high concentrations of organic osmolytes, namely sorbitol, myo-inositol, glycerophosphorylcholine (GPC), and betaine to balance the extracellular hyperosmolality. These organic osmolytes increase cell osmolality without perturbing the intracellular milieu in ways that would degrade the function of cellular macromolecules. The present study surveyed a number of cell lines for the ability to survive in media with high concentrations of NaCl and/or urea and for the accumulation of organic osmolytes. Of the renal cell lines tested, MDCK, GRB-MAL1, and A6 cells proliferated in hyperosmotic media, but medullary interstitial cells LLC-PK1 and LLC-PK3 did not proliferate, nor did nonrenal HTC-BH cells, MDCK, LLC-PK1, and LLC-PK3 cells contained higher concentrations of myo-inositol, GPC, and betaine when cultured in media containing high NaCl (with or without high urea) and much lower or undetectable levels of these osmolytes when grown in isosmotic media. Sorbitol, and to a lesser extent myo-inositol, were elevated in GRB-MAL1 cells in media hyperosmotic with NaCl but not in isosmotic media. There was less accumulation of organic osmolytes when only urea was added to increase osmolality. Thus the same osmolytes were accumulated by one or another cell line in vitro as were previously found in renal medullas. These cell lines provide models for studying osmolyte accumulation.


1994 ◽  
Vol 277 (2) ◽  
pp. 297-307 ◽  
Author(s):  
Michel Bergeron ◽  
Georges Thi�ry ◽  
Fr�d�ric Lenoir ◽  
Marie-C�cile Giocondi ◽  
Christian Le Grimellec

Sign in / Sign up

Export Citation Format

Share Document